Latest Dividend Declarations News

Aspermont Limited reported a 6% rise in revenue and a 12% increase in EBITDA for the year ended September 2025, yet posted a net loss of A$2.576 million. The company’s financial health shows mixed signals amid ongoing operational improvements.

ikeGPS Group Limited reported a modest revenue increase for the first half of FY2025 but faced a significant rise in net losses, with no dividend declared.

NRW Holdings capped FY25 with strong financials and a strategic acquisition, setting the stage for an optimistic FY26. The addition of Fredon Industries expands NRW’s footprint and diversifies its service pillars amid challenging market conditions.

New Zealand King Salmon Investments Limited has revealed a significant 44% decline in revenue alongside a net loss of NZD 6.3 million for the eight months ending September 2025, signaling challenges ahead for the seafood producer.

Ryman Healthcare reported a 13% revenue increase to NZD 413.8 million for H1 2025, yet swung to a significant net loss of NZD 45.2 million and suspended dividends, raising questions about its financial trajectory.

Beacon Minerals Limited reports a substantial 276% increase in gold resources alongside strategic exploration and development plans, setting the stage for extended mine life and shareholder returns.

Select Harvests has reported a striking turnaround in FY2025, with net profit soaring to $31.8 million driven by higher almond prices and operational efficiency, while halving its net debt.

Metro Performance Glass reported a surprising 157% jump in net profit for H1 2025, even as revenue fell 5%, raising questions about underlying business dynamics.

Gentrack Group Limited reported an 8% rise in revenue to NZD 230.2 million and a remarkable 119% jump in net profit for the fiscal year ending September 2025, yet declared no dividend.

Sietel Limited’s preliminary final report for FY2025 reveals a 47% drop in net profit and a 24% fall in total revenues, underscoring a challenging year for the investment management firm.

Oceania Healthcare reports a robust interim result for the six months to September 2025, with significant earnings growth, improved sales, and a reduction in debt gearing. The company’s strategic focus on cost control, capital management, and sustainable care delivery underpins its positive outlook despite housing market headwinds.

Oceania Healthcare has posted a strong half-year turnaround with improved sales, cost savings, and reduced gearing, setting the stage for renewed growth and operational strength.